Skip to Main Content

Allogene Therapeutics

Allogene Therapeutics develops allogeneic CAR T cell therapies, including the AlloCAR T™ platform, targeting blood cancers and autoimmune diseases.

Specifications
Allogene-Therapeutics Homepage 1440px